Skip to main content

 Computer-Aided Design of Imatinib Derivatives to Overcome Drug Resistance in CML

Chronic Myeloid Leukemia (CML) often develops resistance to imatinib due to mutations in the BCR-ABL kinase domain, limiting treatment efficacy. Computer-aided drug design (CADD) enables the development of imatinib derivatives with enhanced binding affinity and efficacy against resistant mutations. Molecular docking, molecular dynamics simulations, and ADMET analysis aid in optimizing novel derivatives to overcome resistance. By targeting key resistant variants, these computational approaches help identify promising drug candidates with improved potency and selectivity. This strategy accelerates drug discovery, offering potential new therapies for CML patients who no longer respond to first-line treatments like imatinib.

Role of Computer-Aided Drug Design (CADD)

Computer-aided drug design (CADD) has emerged as a powerful tool for developing new therapeutic compounds. By leveraging computational techniques such as molecular docking, molecular dynamics (MD) simulations, and quantitative structure-activity relationship (QSAR) modeling, researchers can design and optimize imatinib derivatives with enhanced potency and selectivity.

  1. Molecular Docking:

    • Used to predict the binding affinity of novel imatinib derivatives to both wild-type and mutant BCR-ABL proteins.
    • Helps in identifying molecules with strong interactions and optimal binding conformations.
  2. Molecular Dynamics Simulations:

    • Provides insights into the stability and flexibility of drug-protein interactions over time.
    • Simulates physiological conditions to assess how derivatives behave within a cellular environment.
  3. ADMET Analysis (Absorption, Distribution, Metabolism, Excretion, and Toxicity):

    • Predicts pharmacokinetic and toxicity profiles to identify promising drug candidates.
    • Ensures derivatives have optimal drug-like properties with minimal side effects.

Designing Imatinib Derivatives

Through virtual screening and molecular modifications, researchers can develop novel imatinib analogs with:

  • Improved binding affinity to BCR-ABL, including resistant mutants.
  • Increased hydrophobic interactions, hydrogen bonding, and π-π stacking with key residues.
  • Structural modifications that prevent steric hindrance, allowing better access to the active site.

Potential Impact

By utilizing CADD approaches, researchers can accelerate the discovery of next-generation TKIs that overcome resistance in CML patients. These derivatives could serve as alternatives for patients who fail imatinib therapy, offering new hope in targeted cancer treatment.

International Research Awards on Network Science and Graph Analytics

Visit Our Website : https://networkscience.researchw.com/

Nominate Now : https://networkscience-conferences.researchw.com/award-nomination/?ecategory=Awards&rcategory=Awardee
Contact us : network@researchw.com

Get Connected Here:
*****************

Instagram: https://www.instagram.com/emileyvaruni/
Tumblr: https://www.tumblr.com/emileyvaruni
Pinterest: https://in.pinterest.com/emileyvaruni/
Blogger: https://emileyvaruni.blogspot.com/
Twitter: https://x.com/emileyvaruni
YouTube: https://www.youtube.com/@emileyvaruni

#sciencefather #researchw  #researchawards #NetworkScience #GraphAnalytics  #ResearchAwards  #InnovationInScience #TechResearch  #DataScience #GraphTheory  #ScientificExcellence  #AIandNetworkScience     #Imatinib, #CML, Chronic Myelogenous Leukemia, #DrugResistance, #CancerResearch, #ComputerAidedDesign, #MolecularModeling, #DrugDesign, #Pharmacology, #Chemoinformatics, #CancerTherapy, #BiomedicalResearch, #DrugDiscovery, #MolecularDocking, #OncologyResearch, #TargetedTherapy

Comments

Popular posts from this blog

Global Lighthouse Network

Smart, sustainable manufacturing: 3 lessons from the Global Lighthouse Network Launched in 2018, when more than 70% of factories struggled to scale digital transformation beyond isolated pilots, the Global Lighthouse Network set out to identify the world’s most advanced production sites and create a shared learning journey to up-level the global manufacturing community. In the past seven years, the network has grown from 16 to 201 industrial sites in more than 30 countries and 35 sectors, including the latest cohort of 13 new sites. This growing community of organizations is setting new standards for operational excellence, leveraging advanced technologies to drive growth, productivity, resilience and environmental sustainability. But what exactly is a Global Lighthouse and what has the network achieved? What is the Global Lighthouse Network? The Global Lighthouse Network is a community of operational facilities and value chains that harness digital technologies at scale to ac...

Multi-Modal Data

Multi-Task Federated Split Learning Across Multi-Modal Data with Privacy Preservation With the advancement of federated learning (FL), there is a growing demand for schemes that support multi-task learning on multi-modal data while ensuring robust privacy protection, especially in applications like intelligent connected vehicles. Traditional FL schemes often struggle with the complexities introduced by multi-modal data and diverse task requirements, such as increased communication overhead and computational burdens. In this paper, we propose a novel privacy-preserving scheme for multi-task federated split learning across multi-modal data (MTFSLaMM). Our approach leverages the principles of split learning to partition models between clients and servers, employing a modular design that reduces computational demands on resource-constrained clients. To ensure data privacy, we integrate differential privacy to protect intermediate data and employ homomorphic encryption to safeguard client m...

Quantum Network Nodes

An operating system for executing applications on quantum network nodes The goal of future quantum networks is to enable new internet applications that are impossible to achieve using only classical communication . Up to now, demonstrations of quantum network applications  and functionalities   on quantum processors have been performed in ad hoc software that was specific to the experimental setup, programmed to perform one single task (the application experiment) directly into low-level control devices using expertise in experimental physics.  Here we report on the design and implementation of an architecture capable of executing quantum network applications on quantum processors in platform-independent high-level software. We demonstrate the capability of the architecture to execute applications in high-level software by implementing it as a quantum network operating system-QNodeOS-and executing test programs, including a delegated computation from a client to a server ...